Pfizer May Be Deceiving Customers, Resulting In Them Paying More For Meds E-mail
May 14, 2018

Pfizer may be deceiving customers into thinking they are paying for a stronger medicine and that may not be the case. 

We are investigating claims made against Pfizer, one of the world’s premier biopharmaceutical companies, for potentially misleading consumers to pay more for “Maximum Strength” Robitussin which may contain a lower concentration of one of the two main ingredients: dextromethorphan hydrobromide (“DXM Hbr”) and guaifenesin. Consumers allege that only half of the DXM Hbr is present in the “Maximum Strength” Robitussin.

If you or anyone you know may have purchased Pfizer Maximum Strength Robitussin, please contact Finkelstein Thompson LLP. You can reach us at This email address is being protected from spam bots, you need Javascript enabled to view it or call us toll-free at 1-844-280-5009.